HighLight Capital China acquires stake in biotech company ITM

Gütersloh/Paderborn/Bielefeld/Detmold — High­Light Capi­tal (HLC), a private equity fund from China specia­li­zing in the health­care and biotech sectors, has acqui­red a stake in the biotech company ITM Isotope Tech­no­lo­gies Munich SE (ITM). ITM is a leading radio­phar­maceu­ti­cal biotech company head­quar­te­red in Munich. BRANDI Rechts­an­wälte advi­sed High­Light Capi­tal on the invest­ment in biotech company ITM. With its stra­te­gic invest­ment, High­Light Capi­tal under­lines its commit­ment to finding invest­ments in high-growth compa­nies in the radio­phar­maceu­ti­cal sector. High­Light Capi­tal is a private invest­ment firm dedi­ca­ted to crea­ting long-term value by foste­ring tech­no­lo­gi­cal inno­va­tion. In selec­ting suita­ble compa­nies, HLC draws on in-depth know­ledge of chemis­try, biology and mate­ri­als science, utili­zing its own indus­try rese­arch and compre­hen­sive services. HLC curr­ently mana­ges over 3.8 billion US dollars and is repre­sen­ted in major finan­cial centers such as Tokyo, Shang­hai, Hong Kong and Boston. High­Light Capi­tal recei­ved compre­hen­sive legal advice on the inter­na­tio­nal private equity tran­sac­tion from a cross-loca­­tion M&A team of the law firm BRANDI Rechts­an­wälte led by Güters­loh part­ner Dr. Cars­ten Chris­to­phery. Advi­sor High­Light Capi­tal, Shang­hai, China: BRANDI Rechts­an­wälte Gütersloh/Paderborn/Bielefeld/Detmold

Dr. Cars­ten Chris­to­phery, Part­ner (Lead, Corporate/M&A), Gütersloh
Dr. Franz Tepper, Part­ner (Corporate/M&A), Gütersloh
Dr. Sörren Kiene, Part­ner (Commer­cial), Gütersloh
Dr. Chris­toph Worms, Part­ner (Public Law), Paderborn
Dr. Rüdi­ger Osten, Part­ner (Commer­cial), Detmold
Jannis Riedl, Asso­ciate (Corporate/M&A), Gütersloh
Dr. Clemens Meyer, Asso­ciate (Corporate/M&A), Gütersloh
Feli­cia Deppe-Hietel, Asso­ciate (Public Law), Pader­born Advi­sor ITM Isotope Tech­no­lo­gies Munich SE: JFB Rechts­an­walts­ge­sell­schaft mbH, Münsing
Dr. Justus Fritz Binder, Part­ner (Lead, Corporate/M&A)
Frank Mizera, Asso­ciate (Corporate/M&A)